Overall, the results indicate the driver role of impaired regulation of RAS due to loss of NF1 function in MPNST, and that NF1 GRD alone is able to perform GAP function to decrease RAS activity and downstream effector signaling, particularly RAF-MEK-ERK. This evidence concerns the gene RAF1 and malignant peripheral nerve sheath tumor.